Pressure BioSciences, Inc. (PBI) has launched its biopharmaceuticals contract services business. The launch of this new business has been anticipated following the company’s acquisition of the assets of BaroFold, Inc. in December 2017, including patents, equipment, and other intellectual property relating to Barofold’s high pressure-based protein disaggregation and refolding platform.   PBI expects that the Barofold technology platform will improve the quality and costs of manufact...